Cover
Cover | May 03, 2022 |
Cover [Abstract] | |
Document Type | 8-K/A |
Amendment Flag | true |
Amendment Description | On May 4, 2022, Enveric Biosciences, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Report”) to disclose the filing of a Certificate of Designation with the Delaware Secretary of State fixing the designation, powers, preferences, and rights of the shares of the Company’s Series C Preferred Stock, par value $0.01 per share (“Series C Preferred Stock”) under Items 3.03 and 5.03 of Form 8-K. |
Document Period End Date | May 3, 2022 |
Current Fiscal Year End Date | --12-31 |
Entity File Number | 001-38286 |
Entity Registrant Name | Enveric Biosciences, Inc. |
Entity Central Index Key | 0000890821 |
Entity Tax Identification Number | 95-4484725 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 4851 Tamiami Trail N |
Entity Address, Address Line Two | Suite 200 |
Entity Address, City or Town | Naples |
Entity Address, State or Province | FL |
Entity Address, Postal Zip Code | 34103 |
City Area Code | (239) |
Local Phone Number | 302-1707 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common stock, par value $0.01 per share |
Trading Symbol | ENVB |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |